| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 357 |
| 1 | METHOTREXATE SODIUM | 153 |
| 2 | METHOTREXATE | 127 |
| 3 | ADALIMUMAB | 105 |
| 4 | PREDNISONE | 87 |
| 5 | USTEKINUMAB | 70 |
| 6 | CYCLOSPORINE | 63 |
| 7 | UPADACITINIB | 63 |
| 8 | SECUKINUMAB | 59 |
| 9 | MYCOPHENOLATE MOFETIL | 58 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MECHLORETHAMINE HYDROCHLORIDE | 47 | 0.0209 |
| 1 | BEXAROTENE | 27 | 0.0204 |
| 2 | DELGOCITINIB | 3 | 0.0112 |
| 3 | ACITRETIN | 40 | 0.0081 |
| 4 | ROMIDEPSIN | 12 | 0.0071 |
| 5 | BRODALUMAB | 14 | 0.0068 |
| 6 | MOGAMULIZUMAB-KPKC | 9 | 0.0066 |
| 7 | ABROCITINIB | 24 | 0.0061 |
| 8 | DUVELISIB | 4 | 0.0047 |
| 9 | PRALATREXATE | 3 | 0.0046 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 357 |
| 1 | Corticosteroid [EPC] | 167 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 145 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 129 |
| 4 | Janus Kinase Inhibitor [EPC] | 108 |
| 5 | Interleukin-23 Antagonist [EPC] | 103 |
| 6 | Alkylating Drug [EPC] | 85 |
| 7 | Interleukin-17A Antagonist [EPC] | 73 |
| 8 | Interleukin-12 Antagonist [EPC] | 70 |
| 9 | Retinoid [EPC] | 69 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 14 | 0.0068 |
| 2 | Chemokine Receptor Type 4 Interaction [EPC] | 9 | 0.0066 |
| 3 | CD30-directed Immunoconjugate [EPC] | 48 | 0.0046 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 17 | 0.0029 |
| 5 | Interleukin-13 Antagonist [EPC] | 19 | 0.0028 |
| 6 | Interleukin-17A Antagonist [EPC] | 73 | 0.0020 |
| 7 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 8 | Interferon gamma [EPC] | 2 | 0.0014 |
| 9 | alpha-Hydroxy Acid [EPC] | 3 | 0.0014 |